Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Zhuhai Rundu Pharmaceutical Co., Ltd., a pharmaceutical firm established in 1997 and based in Zhuhai, China, is engaged in the research, production, and worldwide distribution of pharmaceutical components. The company's diverse portfolio of medicinal ingredients targets key therapeutic areas such as cardiovascular health, gastrointestinal conditions, central nervous system (CNS) disorders, and anesthesia. Its offerings include Active Pharmaceutical Ingredients (APIs), intermediate compounds, finished dosage forms (FDFs), and pellets, which are supplied in common formats like capsules, tablets, and injectable solutions.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA, overpriced on P/FC.